AAAAAA

   
Results: 1-8 |
Results: 8
STRUCTURAL OPTIMIZATION AFFORDING ENYL-4-(3-OXO-1,2,4-TRIAZOL-5-YL)METHYLMORPHOLINE, A POTENT, ORALLY-ACTIVE, LONG-ACTING MORPHOLINE ACETALHUMAN NK-1 RECEPTOR ANTAGONIST
Authors: HALE JJ MILLS SG MACCOSS M FINKE PE CASCIERI MA SADOWSKI S BER E CHICCHI GG KURTZ M METZGER J EIERMANN G TSOU NN TATTERSALL FD RUPNIAK NMJ WILLIAMS AR RYCROFT W HARGREAVES R MACINTYRE DE
Citation: Jj. Hale et al., STRUCTURAL OPTIMIZATION AFFORDING ENYL-4-(3-OXO-1,2,4-TRIAZOL-5-YL)METHYLMORPHOLINE, A POTENT, ORALLY-ACTIVE, LONG-ACTING MORPHOLINE ACETALHUMAN NK-1 RECEPTOR ANTAGONIST, Journal of medicinal chemistry, 41(23), 1998, pp. 4607-4614
IN-VITRO AND IN-VIVO PREDICTORS OF THE ANTIEMETIC ACTIVITY OF TACHYKININ NK1 RECEPTOR ANTAGONISTS
Authors: RUPNIAK NMJ TATTERSALL FD WILLIAMS AR RYCROFT W CARLSON EJ CASCIERI MA SADOWSKI S BER E HALE JJ MILLS SG MACCOSS M SEWARD E HUSCROFT I OWEN S SWAIN CJ HILL RG HARGREAVES RJ
Citation: Nmj. Rupniak et al., IN-VITRO AND IN-VIVO PREDICTORS OF THE ANTIEMETIC ACTIVITY OF TACHYKININ NK1 RECEPTOR ANTAGONISTS, European journal of pharmacology, 326(2-3), 1997, pp. 201-209
CHARACTERIZATION OF THE BINDING AND ACTIVITY OF A HIGH-AFFINITY, PSEUDOIRREVERSIBLE MORPHOLINO TACHYKININ NK1 RECEPTOR ANTAGONIST
Authors: CASCIERI MA BER E FONG TM HALE JJ TANG F SHIAO LL MILLS SG MACCOSS M SADOWSKI S TOTA MR STRADER CD
Citation: Ma. Cascieri et al., CHARACTERIZATION OF THE BINDING AND ACTIVITY OF A HIGH-AFFINITY, PSEUDOIRREVERSIBLE MORPHOLINO TACHYKININ NK1 RECEPTOR ANTAGONIST, European journal of pharmacology, 325(2-3), 1997, pp. 253-261
TACHYKININ NK1 RECEPTOR ANTAGONISTS ACT CENTRALLY TO INHIBIT EMESIS INDUCED BY THE CHEMOTHERAPEUTIC AGENT CISPLATIN IN FERRETS
Authors: TATTERSALL FD RYCROFT W FRANCIS B PEARCE D MERCHANT K MACLEOD AM LADDUWAHETTY T KEOWN L SWAIN C BAKER R CASCIERI M BER E METZGER J MACINTYRE DE HILL RG HARGREAVES RJ
Citation: Fd. Tattersall et al., TACHYKININ NK1 RECEPTOR ANTAGONISTS ACT CENTRALLY TO INHIBIT EMESIS INDUCED BY THE CHEMOTHERAPEUTIC AGENT CISPLATIN IN FERRETS, Neuropharmacology, 35(8), 1996, pp. 1121-1129
CHARACTERIZATION OF THE INTERACTION OF DIACYLPIPERAZINE ANTAGONISTS WITH THE HUMAN NEUROKININ-1 RECEPTOR - IDENTIFICATION OF A COMMON BINDING-SITE FOR STRUCTURALLY DISSIMILAR ANTAGONISTS
Authors: CASCIERI MA SHIAO LL MILLS SG MACCOSS M SWAIN CJ YU H BER E SADOWSKI S WU MT STRADER CD FONG TM
Citation: Ma. Cascieri et al., CHARACTERIZATION OF THE INTERACTION OF DIACYLPIPERAZINE ANTAGONISTS WITH THE HUMAN NEUROKININ-1 RECEPTOR - IDENTIFICATION OF A COMMON BINDING-SITE FOR STRUCTURALLY DISSIMILAR ANTAGONISTS, Molecular pharmacology, 47(4), 1995, pp. 660-665
IDENTIFICATION OF L-TRYPTOPHAN DERIVATIVES WITH POTENT AND SELECTIVE ANTAGONIST ACTIVITY AT THE NK1 RECEPTOR
Authors: MACLEOD M MERCHANT KJ BROOKFIELD F KELLEHER F STEVENSON G OWENS AP SWAIN CJ BAKER R CASCIERI MA SADOWSKI S BER E STRADER CD MACINTYRE DE METZGER JM BALL RG
Citation: M. Macleod et al., IDENTIFICATION OF L-TRYPTOPHAN DERIVATIVES WITH POTENT AND SELECTIVE ANTAGONIST ACTIVITY AT THE NK1 RECEPTOR, Journal of medicinal chemistry, 37(9), 1994, pp. 1269-1274
CHARACTERIZATION OF THE INTERACTION OF N-ACYL-L-TRYPTOPHAN BENZYL ESTER NEUROKININ ANTAGONISTS WITH THE HUMAN NEUROKININ-1 RECEPTOR
Authors: CASCIERI MA MACLEOD AM UNDERWOOD D SHIAO LL BER E SADOWSKI S YU H MERCHANT KJ SWAIN CJ STRADER CD FONG TM
Citation: Ma. Cascieri et al., CHARACTERIZATION OF THE INTERACTION OF N-ACYL-L-TRYPTOPHAN BENZYL ESTER NEUROKININ ANTAGONISTS WITH THE HUMAN NEUROKININ-1 RECEPTOR, The Journal of biological chemistry, 269(9), 1994, pp. 6587-6591
N-ACYL-L-TRYPTOPHAN BENZYL-ESTERS - POTENT SUBSTANCE-P RECEPTOR ANTAGONISTS
Authors: MACLEOD AM MERCHANT KJ CASCIERI MA SADOWSKI S BER E SWAIN CJ BAKER R
Citation: Am. Macleod et al., N-ACYL-L-TRYPTOPHAN BENZYL-ESTERS - POTENT SUBSTANCE-P RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 36(14), 1993, pp. 2044-2045
Risultati: 1-8 |